对比增强超声在甲状腺微小乳头状癌中的诊断准确性:按大小分层分析
研究纳入109例甲状腺结节患者(77例病理确诊甲状腺微小乳头状癌,32例结节性甲状腺肿对照),评估三维彩色多普勒超声(3-DCDUS)与对比增强超声(CEUS)的诊断准确性。CEUS与3-DCDUS联合诊断准确性显著优于单独任一方法(p<0.05),而两者单独应用准确性相似(p>0.05)。前后径≥0.66 cm时CEUS诊断准确性显著提高。
要点
- CEUS联合3-DCDUS诊断甲状腺微小乳头状癌的准确性显著优于单独CEUS或3-DCDUS。
- 前后径≥0.66 cm的结节,CEUS诊断恶性准确性显著提高。
- 甲状腺微小乳头状癌多表现为不均匀增强或低增强,结节性甲状腺肿多表现为均匀高增强或等增强。
核心结论
- CEUS有助于判断甲状腺结节的良恶性,前后径≥0.66 cm时诊断准确性显著更优。
研究设计与样本
- 单中心研究,纳入2017年1月至2018年12月中国医科大学附属第一医院109例甲状腺结节患者,其中甲状腺微小乳头状癌77例(试验组),结节性甲状腺肿32例(对照组),所有结节最大径≤1.0 cm。
- 所有患者先行3-DCDUS检查并进行TI-RADS分级,再行CEUS检查,以术后病理为参考标准。
- 采用受试者工作特征曲线分析结节前后径,确定CEUS诊断恶性的截断值。
关键影像表现/征象
- 试验组CEUS表现:不均匀增强或低增强55例,均匀高增强或均匀等增强22例。
- 对照组CEUS表现:不均匀增强或低增强12例,均匀高增强或均匀等增强20例。
诊断标准与关键数值
- 试验组TI-RADS分级:4a类23例,4b类40例,4c类14例;对照组TI-RADS分级:3类1例,4类21例,4b类10例。
- CEUS诊断恶性的前后径截断值为0.66 cm,此时约登指数最大。
- 3-DCDUS或CEUS单独诊断与3-DCDUS+CEUS联合诊断的准确性差异有统计学意义(p<0.05),而3-DCDUS与CEUS之间差异无统计学意义(p>0.05)。
- 排除前后径<0.66 cm的结节后,CEUS和3-DCDUS+CEUS的诊断准确性均显著提高(p<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
We explored the diagnostic accuracy of ultrasonography (US) in papillary thyroid microcarcinoma (PTMC), studying nodular growths according to size via 3-D color Doppler US (3-DCDUS) and contrast-enhanced US (CEUS). A total of 109 patients undergoing CEUS and surgery of thyroid nodules at the First Hospital of China Medical University between January 2017 and December 2018 were selected for the study, including 77 with post-operative pathologically confirmed PTMC (test group) and 32 with nodular goiter (controls). All nodules were ≤1.0 cm in maximum diameter. After 3-DCDUS, each patient underwent Thyroid Imaging Reporting and Data System (TI-RADS) grading. In both groups, receiver operating characteristic curve analysis of anteroposterior (AP) nodule diameters was conducted, establishing a cutpoint for probable malignancy by CEUS. In the test group (n = 77), grading was as follows: TI-RADS 4a, 23; TI-RADS 4b, 40; TI-RADS 4c, 14. More patients had heterogeneous enhancement or hypo-enhancement (n = 55) than uniform hyper-enhancement or uniform iso-enhancement (n = 22) by contrast-enhanced ultrasonography (CEUS). Control group (n = 32) grading was as follows: TI-RADS 3, 1; TI-RADS 4, 21; TI-RADS 4b, 10. Fewer patients had heterogeneous enhancement or hypo-enhancement (n = 12) than uniform hyper-enhancement or uniform iso-enhancement (n = 20) by CEUS. The diagnostic accuracy of 3-DCDUS or CEUS differed significantly from that of 3-DCD-US + CEUS (p < 0.05), whereas 3-DCDUS and CEUS performed similarly (p > 0.05). At AP diameters of 0.66 cm, the Youden index for diagnosing malignancy by CEUS was maximal. When nodules below this threshold were excluded, both CEUS and 3-DCDUS + CEUS improved significantly in diagnostic accuracy (p < 0.05). CEUS is useful in determining the status (benign vs. malignant) of thyroid nodules, with significantly better accuracy at AP diameters ≥0.66 cm.
引用
- Huang K, Bai Z, Bian D, et al. Diagnostic Accuracy of Contrast-Enhanced Ultrasonography in Papillary Thyroid Microcarcinoma Stratified by Size. Ultrasound Med Biol. 2019. PMID: 31703968. doi:10.1016/j.ultrasmedbio.2019.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。